Tag: patent litigation
Tentative approval from the FDA lets generic drug makers prepare for market entry while patent lawsuits play out. It’s not final approval-but it’s the key to being first to market when the patent expires.
Authorized generics let brand drug companies launch their own generic versions, undercutting independent competitors and reducing true market competition. Here’s how they distort the system meant to lower drug prices.
